Loss of RIPK3 leads to the activation of the Wnt/β-catenin signaling pathway in the ripk3-/- colon cancer mouse model, and enhances inflammation, immune cell infiltration, and angiogenesis 33. This evidence concerns the gene RIPK3 and malignant colon neoplasm.